Ampere Generator
St Jude Medical · Decision date Aug 7, 2026
What did the FDA approve?
FDA records P960016/S094 as a supplement to PMA P960016, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Aug 7, 2026.
FDA approval order statement
approval for firmware changes to the TactiSys Quartz Equipment v1.8.0 and Ampere Generator v1.2.0 to maintain compatibility with the TactiFlex Duo Ablation Catheter, Sensor Enabled
- Regulatory pathway
- PMA supplement
- Supplement type
- Real-Time Process
- Clinical specialty
- Cardiovascular
- Decision date
- Aug 7, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P960016/S094
- Regulatory pathway
- PMA supplement
- Applicant
- St Jude Medical
- Product code
- LPB
- Decision code
- APPR
- Decision date
- Aug 7, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Cardiac ablation percutaneous catheter.
- Applicant
- St Jude Medical
- Product code
- LPB
- FDA device class
- 3
Review the original FDA PMA listing for the original approval scope and linked supplements.
FDA decision timeline
P960016/S093 · Related supplement
Livewire TC XLS
P960016/S094 received
Application receipt date recorded by FDA.
P960016/S094 · FDA decision
Real-Time Process
Timeline entries are records held by MedtechLedger for P960016. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P960016
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Livewire TC XLSP960016/S093 | St Jude Medical | PMA supplement | Jan 15, 2026 | FDA |
Explore the linked device profile
Other records with product code LPB
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Biosense Webster, Inc. | PMA supplement | Sep 15, 2026 | FDA | |
| Irvine Biomedical, Inc. | PMA supplement | Sep 3, 2026 | FDA | |
Ampere GeneratorP040014/S051 | Irvine Biomedical, Inc. | PMA supplement | Aug 7, 2026 | FDA |
MAGiC Ablation CatheterP240014/S001 | Stereotaxis, Inc. | PMA supplement | Jul 31, 2026 | FDA |
| Medtronic Cryocath, LP | PMA supplement | Apr 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
St Jude Medical
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 14900 Minnetonka Ind Rd., Minnetonka, MN, 55345
Sources and methodology
- Original FDA record: P960016/S094
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

